IDXX News and Press, IDEXX Laboratories Inc. From 11/01/22

IDEXX Laboratories, Inc. (IDXX) Q3 2022 Earnings Conference Call November 1, 2022, 08:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - CEO Conference Call Participants Chris Schott - JPMorgan Erin Wright - Morgan Stanley Jon Block -...

IDEXX Laboratories ( NASDAQ: IDXX ) stock rose ~7% on Tuesday after Q3 results beat estimates, however the company narrowed its FY22 outlook. Comparable EPS growth was $2.23, up +12.6% Y/Y. Revenue increased ~3.9% Y/Y to $841.66M, driven by Companion Animal G...

Shares of IDEXX Laboratories (NASDAQ: IDXX) were moving higher today after the veterinary healthcare company posted better-than-expected results in its third-quarter earnings but slashed its full-year earnings guidance due to the stronger dollar and higher interest rates. As of ...

The following slide deck was published by IDEXX Laboratories, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: IDEXX Laboratories, Inc. 2022 Q3 - Results - Earnings Call Presentation

IDEXX Laboratories press release ( NASDAQ: IDXX ): Q3 Non-GAAP EPS of $2.23 beats by $0.19 . Revenue of $841.66M (+3.9% Y/Y) beats by $11.66M . FY2022 Outlook: Revenue of $3.325B to $3.265B vs. prior view of $3.305B to $3.385B and consensus of $3.37B; ...

IDEXX Laboratories ( NASDAQ: IDXX ) is scheduled to announce Q3 earnings results on Tuesday, November 1st, before market open. The consensus EPS Estimate is $2.04 (+4.1% Y/Y) and the consensus Revenue Estimate is $830M (+2.4% Y/Y). Over the last 1 year, IDXX has beat...

Summary FIW holds 36 companies that derive a substantial portion of their revenues from the potable and wastewater industry. The fund's popularity is increasing, now with $1.14 billion in AUM. However, even considering the sharp decline this year, FIW trades at an expensive 26.77x...

Summary IDEXX Laboratories is operating in an industry with good tailwinds. Over the last decade, IDEXX Laboratories returned 22% annually, but future returns will likely be much lower. The company has many characteristics of a high-quality business. IDEXX Laboratories' va...

Summary We examine the relationship between volatility and risk. Outline our Bayesian Monte Carlo technique for automated portfolio construction. Back-tested results are summarized. Optimized Portfolio Construction using Bayesian Analysis With macro headwinds pic...

Summary Baxter International has had a rough year or so, with shares declining far more than the market has. Some of this was justified by the company's high share price and weakening fundamentals. But given where shares are today, the firm does seem to offer some upside for i...